Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus
- 1 August 2008
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 110 (2) , 196-201
- https://doi.org/10.1016/j.ygyno.2008.04.002
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Can a Preoperative CA 125 Level Be a Criterion for Full Pelvic Lymphadenectomy in Surgical Staging of Endometrial Cancer?Gynecologic Oncology, 2002
- Tissue and serum CA125 expression in endometrial cancerInternational Journal of Gynecologic Cancer, 2002
- Value of Preoperative CA 125 Level in the Management of Uterine Cancer and Prediction of Clinical OutcomePublished by Wolters Kluwer Health ,1998
- Is OVX1 a Suitable Marker for Endometrial Cancer?Gynecologic Oncology, 1997
- Significance of a Single CA 125 Assay Combined with Ultrasound in the Early Detection of Ovarian and Endometrial CancerGynecologic Oncology, 1997
- Serum and tissue measurements of CA72-4 in patients with endometrial carcinoma.Journal of Clinical Pathology, 1996
- Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancerAmerican Journal of Obstetrics and Gynecology, 1996
- Combined Assay of Serum Levels of CA125 and CA19-9 in Endometrial CarcinomaGynecologic Oncology, 1994
- Combined Use of CA 125 and CA 15-3 in Patients with Endometrial CarcinomaGynecologic Oncology, 1994